Fusion Antibodies PLC
LSE:FAB
Fusion Antibodies PLC
LSE:FAB
Price:
3.4 GBX
Market Closed
Updated:
May 14, 2024
Fusion Antibodies PLC
Accounts Receivables
|
Fusion Antibodies PLC
Accounts Receivables Peer Comparison
Comparables:
ONT
O
ORPH
DXRX
ERGO
HVO
Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Fusion Antibodies PLC
LSE:FAB
|
Accounts Receivables
£471k
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
|
Oxford Nanopore Technologies PLC
LSE:ONT
|
Accounts Receivables
£61.5m
|
CAGR 3-Years
6%
|
CAGR 5-Years
39%
|
CAGR 10-Years
N/A
|
|
O
|
Open Orphan PLC
LSE:ORPH
|
Accounts Receivables
£8.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Diaceutics PLC
LSE:DXRX
|
Accounts Receivables
£8.4m
|
CAGR 3-Years
11%
|
CAGR 5-Years
38%
|
CAGR 10-Years
N/A
|
|
|
Ergomed PLC
LSE:ERGO
|
Accounts Receivables
£31.3m
|
CAGR 3-Years
17%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
|
hVIVO PLC
LSE:HVO
|
Accounts Receivables
£14.6m
|
CAGR 3-Years
14%
|
CAGR 5-Years
22%
|
CAGR 10-Years
41%
|
See Also
What is Fusion Antibodies PLC's Accounts Receivables?
Accounts Receivables
471k
GBP
471k
GBP
Based on the financial report for Sep 30, 2023, Fusion Antibodies PLC's Accounts Receivables amounts to 471k GBP.
What is Fusion Antibodies PLC's Accounts Receivables growth rate?
Accounts Receivables CAGR 5Y
-6%
-6%
Over the last year, the Accounts Receivables growth was -61%. The average annual Accounts Receivables growth rates for Fusion Antibodies PLC have been -26% over the past three years , -6% over the past five years .
You don't have any saved screeners yet
